Clinical characteristics of BAD clusters
| BAD_1 n=25 | BAD_2 n=25 | P value | |
| Sex | |||
| Female % | 44 | 28 | 0.38 |
| Male % | 56 | 72 | |
| Age | 53.6±11.3 | 46.8±13.5 | 0.06 |
| Body mass index (kg/m2) | 31.9±4.5 | 27.9±4.8 | 0.004 |
| Alanine transaminase (U/L) | 39.7±16.0 | 26.5±12.9 | 0.003 |
| Alkaline phosphatase (U/L) | 81.8±20.9 | 74.6±13.0 | 0.16 |
| Bilirubin (mg/dL) | 0.58±0.20 | 0.56±0.17 | 0.83 |
| FGF19 (pg/ml) | 109.3±85.22 | 101.0±77.88 | 0.66 |
| Triglycerides (mmol/l) | 2.1±1.0 | 2.6±2.4 | 0.89 |
| SeHCAT (%) | 3.53±2.96 | 4.13±3.50 | 0.52 |
| Stools/day (baseline) | 3.82±1.89 | 3.25±1.77 | 0.28 |
The values are expressed by mean±SD. P values arise from paired t-tests or Mann-Whitney test.
Statistically significant P values are marked with bold font.
BAD, bile acid diarrhoea; FGF19, fibroblast growth factor 19; SeHCAT, 75selenium homotaurocholic acid test.